FISIOLOGÍA Y FARMACOLOGÍA
Departamento
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (7)
2023
-
Cohort Profile: PISCIS, a population-based cohort of people living with HIV in Catalonia and Balearic Islands
International Journal of Epidemiology, Vol. 52, Núm. 4, pp. E241-E252
-
Key Genes of the Immune System and Predisposition to Acquired Hemophilia A: Evidence from a Spanish Cohort of 49 Patients Using Next-Generation Sequencing
International Journal of Molecular Sciences, Vol. 24, Núm. 22
-
Protective potential of the gallbladder in primary sclerosing cholangitis
JHEP Reports, Vol. 5, Núm. 4
2022
-
RICORS2040: The need for collaborative research in chronic kidney disease
Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387
2021
-
Management of acquired hemophilia A: results from the Spanish registry
Blood Advances, Vol. 5, Núm. 19, pp. 3821-3829
-
NADPH oxidase 4 (Nox4) deletion accelerates liver regeneration in mice
Redox Biology, Vol. 40
2015
-
The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
Oncotarget, Vol. 6, Núm. 22, pp. 18875-18890